Alphacentric Lifesci Healthcare Fund Investor Sentiment

LYFCX Fund  USD 13.31  0.08  0.60%   
Slightly above 53% of Alphacentric Lifesci's investor base is interested to short. The analysis of overall sentiment of trading Alphacentric Lifesci Healthcare mutual fund suggests that many investors are impartial at this time. Alphacentric Lifesci's investing sentiment can be driven by a variety of factors including economic data, Alphacentric Lifesci's earnings reports, geopolitical events, and overall market trends.
  
over a year ago at news.google.com         
Morgan Stanley Maintains Airsculpt Technologies Equal ... - Nasdaq
Google News at Macroaxis
over a year ago at news.google.com         
Morgan Stanley Maintains Airsculpt Technologies Equal ... - Nasdaq
Google News at Macroaxis
over a year ago at news.google.com         
Unusual Call Option Trade in Airsculpt Technologies Worth ... - Nasdaq
Google News at Macroaxis
a day ago at gurufocus.com         
Gilead Sciences Inc Announces Promising Results from Phase 3 HIV Prevention Trial
Gurufocus Stories at Macroaxis
3 days ago at thelincolnianonline.com         
Gilead Sciences, Inc. Holdings Raised by Pekin Hardy Strauss Inc.
news
few days ago at investing.com         
Earnings call Legend Biotech sees strong Q3 growth with CARVICTI
Investing News at Macroaxis
few days ago at gurufocus.com         
Gilead Announces Layoffs Amid Strong Q3 Performance, HIV Drug Sales Surge
Gurufocus Stories at Macroaxis
few days ago at businesswire.com         
The Childrens Inn at NIH Announces 1 Million Grant From Gilead Sciences, Inc.
businesswire News
six days ago at thelincolnianonline.com         
Cypress Capital Group Reduces Holdings in Gilead Sciences, Inc.
news
over a week ago at finance.yahoo.com         
FirstLight and Maine Connectivity Authority Sign Agreement to Build 450 Miles of Fiber in Western Ma...
Yahoo News
over a week ago at finance.yahoo.com         
Mt. Gilead KOA Holiday Named Kampgrounds of America, Inc.s 2025 Campground of the Year
Yahoo News
over a week ago at businesswire.com         
TOUCH, la Alianza de Personas de la Raza Negra contra el Cncer de Seno y sus aliados presentan el ce...
businesswire News
over a week ago at investing.com         
arcellx CFO Michelle Gilson sells 156,508 in shares
Investing News at Macroaxis
a day ago at thelincolnianonline.com         
Insider Selling Vertex, Inc. General Counsel Sells 3,020 Shares of Stock
news
3 days ago at finance.yahoo.com         
Vertex Pharmaceuticals shareholders are still up 137 percent over 3 years despite pulling back 3.4 p...
Yahoo News
few days ago at fool.com         
Down 47 percent Since March, Is CRISPR Therapeutics Stock a Buy on the Dip?
fool News
few days ago at thelincolnianonline.com         
Pacer Advisors Inc. Sells 5,885 Shares of Vertex Pharmaceuticals Incorporated
news
few days ago at fool.com         
Got 500 1 Biotech Stock to Buy and Hold Forever
fool News
few days ago at finance.yahoo.com         
This Week in Tech News 12 Stories You Need to See
Yahoo News
six days ago at finance.yahoo.com         
KPMG plans 100M Google Cloud investment
Yahoo News
six days ago at investing.com         
BofA flags Vertex Pharma stock at risk of double top breakdown
Investing News at Macroaxis
over a week ago at finance.yahoo.com         
Vertex Pharmaceuticals Incorporated Shares Could Be 48 percent Below Their Intrinsic Value Estimate
Yahoo News
over a week ago at finance.yahoo.com         
Cision to Transform AI-Powered Communications in Collaboration with Google Cloud
Yahoo News
3 days ago at www.macroaxis.com         
Disposition of 9034 shares by Pomerantz Roger of Viracta Therapeutics subject to Rule 16b-3
Macroaxis News
over a week ago at thelincolnianonline.com         
Contrasting ALX Oncology Viracta Therapeutics
news
over two weeks ago at finance.yahoo.com         
Viracta Therapeutics Announces Reprioritization of Resources to Enhance Focus on Nana-val Developmen...
Yahoo News
over a month ago at news.google.com         
Viracta Therapeutics SWOT analysis narrowed focus shapes stock outlook - Investing.com
Google News at Macroaxis
over three months ago at www.macroaxis.com         
Disposition of 9034 shares by Pomerantz Roger of Viracta Therapeutics subject to Rule 16b-3
Macroaxis News
over three months ago at finance.yahoo.com         
Thornburg Names Heads of Equities and Fixed Income
Yahoo News
over three months ago at investorplace.com         
VIRX Stock Earnings Viracta Therapeutics Beats EPS for Q2 2024
sbwire news
over three months ago at seekingalpha.com         
Viracta stock jumps after corporate update
seekingalpha News
over three months ago at globenewswire.com         
Viracta Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
Macroaxis News: globenewswire.com
over three months ago at news.google.com         
VIRX stock touches 52-week low at 0.43 amid market challenges - Investing.com
Google News at Macroaxis
a day ago at finance.yahoo.com         
3d Systems Q3 2024 Earnings Call Transcript
Yahoo News
3 days ago at finance.yahoo.com         
Disposition of 100 shares by Michael Benkowitz of United Therapeutics at 376.18 subject to Rule 16b-...
Yahoo News
six days ago at news.google.com         
Disposition of 7700 shares by Mahon Paul A of United Therapeutics at 367.36 subject to Rule 16b-3
Google News at Macroaxis
over a week ago at www.macroaxis.com         
Disposition of 237 shares by Michael Benkowitz of United Therapeutics at 362.0202 subject to Rule 16...
Macroaxis News
over a week ago at gurufocus.com         
Avoro Capital Advisors LLC Increases Stake in Ascendis Pharma AS
Gurufocus Stories at Macroaxis
over two weeks ago at thelincolnianonline.com         
United Therapeutics Co. Director Judy D. Olian Sells 1,750 Shares
news
over two weeks ago at gurufocus.com         
United Therapeutics Stock Dips Amid Broader Biotech Industry Movements
Gurufocus Stories at Macroaxis
over two weeks ago at thelincolnianonline.com         
Lifestyle Asset Management Inc. Sells 95 Shares of United Therapeutics Co.
news
over two weeks ago at gurufocus.com         
Insider Sale Director Richard Giltner Sells 10,000 Shares of United Therapeutics Corp
Gurufocus Stories at Macroaxis
over two weeks ago at thelincolnianonline.com         
HMS Capital Management LLC Buys New Shares in United Therapeutics Co.
news
a minute ago at finance.yahoo.com         
Genethon Pursues Different Strategies for Ensuring Patient Access to Gene Therapies for Rare Disease...
Yahoo News
2 days ago at businesswire.com         
Disposition of 11723 shares by Dallan Murray of Sarepta Therapeutics at 128.67 subject to Rule 16b-3
businesswire News
few days ago at www.macroaxis.com         
Disposition of 11723 shares by Dallan Murray of Sarepta Therapeutics at 128.67 subject to Rule 16b-3
Macroaxis News
few days ago at thelincolnianonline.com         
Disposition of 11723 shares by Dallan Murray of Sarepta Therapeutics at 128.67 subject to Rule 16b-3
news
over a week ago at investing.com         
Sarepta stock outlook strong, says Piper, as rivals show early-stage DMD data
Investing News at Macroaxis
over a week ago at finance.yahoo.com         
Disposition of 4558 shares by Rodino-klapac Louise of Sarepta Therapeutics at 102.89 subject to Rule...
Yahoo News
over a week ago at thelincolnianonline.com         
Disposition of 11723 shares by Dallan Murray of Sarepta Therapeutics at 128.67 subject to Rule 16b-3
news
over a week ago at gurufocus.com         
Disposition of 11723 shares by Dallan Murray of Sarepta Therapeutics at 128.67 subject to Rule 16b-3
Gurufocus Stories at Macroaxis
over two weeks ago at gurufocus.com         
Capital International Investors Expands Stake in Sarepta Therapeutics Inc
Gurufocus Stories at Macroaxis
over two weeks ago at www.macroaxis.com         
Disposition of 11723 shares by Dallan Murray of Sarepta Therapeutics at 128.67 subject to Rule 16b-3
Macroaxis News
a day ago at gurufocus.com         
Regeneron Pharmaceuticals Inc Faces Legal Scrutiny Over Alleged Medicare Fraud
Gurufocus Stories at Macroaxis
3 days ago at investing.com         
Earnings call BioLineRx announces Q3 results and strategic shifts
Investing News at Macroaxis
few days ago at finance.yahoo.com         
Regeneron Pharmaceuticals shareholders have earned a 15 percent CAGR over the last five years
Yahoo News
few days ago at thelincolnianonline.com         
Regeneron Pharmaceuticals Sets New 1-Year Low Heres Why
news
few days ago at businesswire.com         
BioFuture 2024 Wraps Up Hundreds of High-Profile Attendees Joined Record Numbers of Investors and Me...
businesswire News
six days ago at thelincolnianonline.com         
Regeneron Pharmaceuticals, Inc. Shares Purchased by Cornerstone Advisors LLC
news
six days ago at finance.yahoo.com         
Vyriad signs huge deal with Novartis to develop new cancer treatments
Yahoo News
over a week ago at finance.yahoo.com         
China-based biotech Laekna teams up with Lilly to develop muscle preserving obesity drug
Yahoo News
over a week ago at scientificamerican.com         
Readers Respond to the JulyAugust 2024 Issue
news
over a week ago at finance.yahoo.com         
Regeneron Pharmaceuticals, Inc. Among the Best Genomics Stocks to Buy Right Now
Yahoo News
six days ago at globenewswire.com         
uniQure Announces Dosing of First Patient in GenTLE Phase IIIa Clinical Trial of AMT-260 for the Tre...
Macroaxis News: globenewswire.com
six days ago at thelincolnianonline.com         
uniQure Announces Dosing of First Patient in GenTLE Phase IIIa Clinical Trial of AMT-260 for Refract...
news
over two weeks ago at thelincolnianonline.com         
Royal Bank of Canada Has Lowered Expectations for uniQure Stock Price
news
over two weeks ago at finance.yahoo.com         
What Does The Future Hold For uniQure N.V. These Analysts Have Been Cutting Their Estimates
Yahoo News
over three weeks ago at finance.yahoo.com         
UniQure Q3 Earnings Snapshot
Yahoo News
over three weeks ago at zacks.com         
Select Medical Q3 Earnings and Revenues Surpass Estimates
zacks News
over a month ago at thelincolnianonline.com         
uniQure Raised to Sell at StockNews.com
news
over a month ago at finance.yahoo.com         
uniQure Announces Dosing of First Patient in Phase III Clinical Trial of AMT-162 for the Treatment S...
Yahoo News
over a month ago at zacks.com         
Strength Seen in Dianthus Therapeutics, Inc. Can Its 5.7 percent Jump Turn into More Strength?
zacks News
over two months ago at www.macroaxis.com         
Acquisition by Gut Robert of 17060 shares of Uniqure NV at 20.18 subject to Rule 16b-3
Macroaxis News
over a year ago at news.google.com         
Nivolumab Plus Relatlimab Induces Durable Responses in ... - OncLive
Google News at Macroaxis
a minute ago at finance.yahoo.com         
Merck and GTRI to develop gene therapy for Parkinsons disease
Yahoo News
2 days ago at accesswire.com         
Revolutionizing Healthcare Lexaria Highlights Expanding Therapeutic Benefits of GLP-1 Drugs
news
3 days ago at finance.yahoo.com         
Exelixis Stock Surges 25 percent in a Month Time to Buy or Sell?
Yahoo News
few days ago at businesswire.com         
TME PHARMA ANNONCE LA PRSENTATION DUN POSTER PAR LE NATIONAL CANCER INSTITUTE AMRICAIN SUR LINHIBITI...
businesswire News
few days ago at finance.yahoo.com         
Hedge Funds Bet Big On Merck Co. Top Healthcare Stock to Watch
Yahoo News
few days ago at bizjournals.com         
St. Louis public company CEO named to Merck board
bizjournals News
few days ago at gurufocus.com         
Merck Recommends Rejection of TRC Capitals Mini-Tender Offer
Gurufocus Stories at Macroaxis
six days ago at thelincolnianonline.com         
Merck Co., Inc. Shares Acquired by Cypress Capital Group
news
six days ago at finance.yahoo.com         
Top Analyst Reports for Broadcom, Merck Qualcomm
Yahoo News
over a week ago at finance.yahoo.com         
Merck Foundation Announces 17 Million U.S. Initiative To Expand Access to High-Quality Cardiac Care
Yahoo News
a minute ago at simplywall.st         
Jazz Pharmaceuticals investors are sitting on a loss of 20 percent if they invested a year ago
Simply Wall St News at Macroaxis
3 days ago at finance.yahoo.com         
Roche receives FDA approval for first companion diagnostic to identify patients with biliary tract c...
Yahoo News
few days ago at finance.yahoo.com         
FDA Roundup November 22, 2024
Yahoo News
six days ago at benzinga.com         
FDA Greenlights Jazz Pharmas Cancer Drug, A Milestone For Zymework
benzinga news
over a week ago at finance.yahoo.com         
Avextra Portugal Unveils Advanced Breeding Program to Develop Proprietary THC and CBD Cultivars, Est...
Yahoo News
over a week ago at finance.yahoo.com         
Should Value Investors Buy Jazz Pharmaceuticals Stock?
Yahoo News
over a week ago at insidermonkey.com         
Is Jazz Pharmaceuticals plc the Best Immunotherapy Stock to Buy Now?
insidermonkey News
over a week ago at finance.yahoo.com         
Jazz Pharmaceuticals Performance Is Even Better Than Its Earnings Suggest
Yahoo News
over a week ago at zacks.com         
Is the Options Market Predicting a Spike in Jazz Stock?
zacks News
over two weeks ago at finance.yahoo.com         
Wall Street Analysts See a 37.65 percent Upside in Jazz Can the Stock Really Move This High?
Yahoo News
2 days ago at businesswire.com         
Incyte stellt auf der ASH-Jahrestagung 2024 neue Daten vor, darunter eine brandaktuelle mndliche Prs...
businesswire News
3 days ago at investing.com         
Incyte shares target lifted, buy rating on povorcitinib sales outlook
Investing News at Macroaxis
few days ago at finance.yahoo.com         
Goldman Sachs Incyte Corporation Is A Top Growth Investor Stock
Yahoo News
few days ago at finance.yahoo.com         
Top Research Reports for GE Aerospace, Fomento Economico Waste Management
Yahoo News
over a week ago at thelincolnianonline.com         
Incyte Co. Shares Sold by Connor Clark Lunn Investment Management Ltd.
news
over a week ago at finance.yahoo.com         
Incytes 750 Million Escient Deal Faces Setback With Toxicology Issues In Two Investigational Drugs, ...
Yahoo News
over a week ago at smh.com.au         
ASX set to slip, global markets fall on rising Russia-Ukraine tensions
news
over a week ago at seekingalpha.com         
Incyte pares some losses on report of potential Merck takeover interest
seekingalpha News
over a week ago at insidermonkey.com         
Is Incyt Corporation the Best Immunotherapy Stock to Buy Now?
insidermonkey News
over a week ago at finance.yahoo.com         
Heres How Jakafis Patent Expiry Impacts Incyte Corporations Growth Prospects
Yahoo News
3 days ago at simplywall.st         
Have Immunovant Insiders Been Selling Stock?
Simply Wall St News at Macroaxis
few days ago at investing.com         
Immunovant CFO Eva Renee Barnett sells 106,228 in stock
Investing News at Macroaxis
over a week ago at news.google.com         
Immunovant stock hits 52-week low at 24.66 amid market shifts - Investing.com
Google News at Macroaxis
over a week ago at gurufocus.com         
ARMISTICE CAPITAL, LLC Acquires New Stake in Trevena Inc
Gurufocus Stories at Macroaxis
over a week ago at gurufocus.com         
Armistice Capital, LLCs Strategic Acquisition in Accelerate Diagnostics Inc
Gurufocus Stories at Macroaxis
over two weeks ago at zacks.com         
Immunovants Q2 Loss Wider Than Expected, Pipeline in Focus
zacks News
over three weeks ago at www.macroaxis.com         
Disposition of 2362 shares by Macias William L. of Immunovant at 29.64 subject to Rule 16b-3
Macroaxis News
over a month ago at investing.com         
Immunovants chief medical officer sells 94,171 in stock
Investing News at Macroaxis
over a month ago at investing.com         
Immunovants chief medical officer William Macias sells 91,782 in stock
Investing News at Macroaxis
over a month ago at investing.com         
Acquisition by Julia Butchko of 54978 shares of Immunovant subject to Rule 16b-3
Investing News at Macroaxis
over a year ago at www.macroaxis.com         
Disposition of 110447 shares by Thomas Watkins of Horizon Pharma subject to Rule 16b-3
Macroaxis News
over a year ago at news.google.com         
Institutional owners may consider drastic measures as Vir Biotechnology, Inc.s recent US85m drop add...
Google News at Macroaxis
over a year ago at businesswire.com         
Horizon Therapeutics plc Rule 2.12 Announcement
businesswire News
over a year ago at benzinga.com         
Heres How Much 1000 Invested In Horizon Therapeutics 10 Years Ago Would Be Worth Today
benzinga news
over a year ago at news.google.com         
U.S. FTC allows Amgen to move forward with 27.8 bln Horizon deal - CNBC - Marketscreener.com
Google News at Macroaxis
over a year ago at thelincolnianonline.com         
Toronto Dominion Bank Buys 185,145 Shares of Horizon Therapeutics Public Limited
news
over a year ago at finance.yahoo.com         
Horizon Up as FTC Pauses Acquisition by Amgen Lawsuit
Yahoo News
over a year ago at finance.yahoo.com         
Horizon Therapeutics plc Ranks First in Overall Corporate Reputation by Rare Disease Patient Advocac...
Yahoo News
over a year ago at marketwatch.com         
George Soros has a big stake in this stock but its posted a roughly 9 percent loss this year. Are th...
marketwatch News
over a year ago at thelincolnianonline.com         
Horizon Therapeutics Public Issues Earnings Results
news
a day ago at gurufocus.com         
Galapagos NV Stock Surges Amid Strong Industry Performance
Gurufocus Stories at Macroaxis
over a week ago at gurufocus.com         
Stonepine Capital Management, LLC Increases Stake in Verastem Inc
Gurufocus Stories at Macroaxis
over two weeks ago at gurufocus.com         
Prosight Management, LP Expands Stake in ADC Therapeutics SA
Gurufocus Stories at Macroaxis
over three weeks ago at insidermonkey.com         
Galapagos NV Q3 2024 Earnings Call Transcript
insidermonkey News
over three weeks ago at seekingalpha.com         
Galapagos reports 9M results
seekingalpha News
over three months ago at zacks.com         
Biotech Stock Roundup REGNs Drug Approval, LXRX, RYTM Stocks Gain on Update More
zacks News
over three months ago at zacks.com         
Galapagos Up on FDA Nod to Begin Phase III Lymphoma Study
zacks News
over three months ago at benzinga.com         
Galapagos receives transparency notification from FMR LLC
benzinga news
over three months ago at gurufocus.com         
Galapagos NV Earnings Call Transcript Highlights Strong Cash Position and ...
Gurufocus Stories at Macroaxis
over three months ago at benzinga.com         
FDA Approves Adaptimmune Therapeutics Engineered Cell Therapy As First For Solid Tumor And New Thera...
benzinga news
a day ago at investing.com         
ACADIA shares reiterate outperform rating on recent in-licensing
Investing News at Macroaxis
3 days ago at gurufocus.com         
ACADIA HEALTHCARE ALERT Bragar Eagel Squire, P.C. ...
Gurufocus Stories at Macroaxis
over a week ago at investing.com         
Acadia Pharmaceuticals announces executive shakeup
Investing News at Macroaxis
over a week ago at investing.com         
Acadia Pharmaceuticals CFO sells shares worth 172,453
Investing News at Macroaxis
over a week ago at www.macroaxis.com         
Disposition of 9913 shares by Mark Schneyer of ACADIA Pharmaceuticals subject to Rule 16b-3
Macroaxis News
over a week ago at businesswire.com         
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635
businesswire News
over two weeks ago at zacks.com         
Heres Why Acadia Pharmaceuticals is a Strong Momentum Stock
zacks News
over two weeks ago at prnewswire.com         
ACADIA HEALTHCARE SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL KAHN SWICK FOTI, LLC REMIND...
prnewswire News
over two weeks ago at simplywall.st         
ACADIA Pharmaceuticals Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predi...
Simply Wall St News at Macroaxis
over two weeks ago at thelincolnianonline.com         
ACADIA Pharmaceuticals Posts Earnings Results
news
a day ago at finance.yahoo.com         
Exelixis to Webcast Fireside Chats as Part of Investor Conferences in December
Yahoo News
3 days ago at globenewswire.com         
EXEL Industries Guillaume Jacq appointed Chief Financial Officer of the EXEL Industries Group
Macroaxis News: globenewswire.com
few days ago at www.macroaxis.com         
Disposition of 10000 shares by Haley Patrick J. of Exelixis at 35.27 subject to Rule 16b-3
Macroaxis News
six days ago at zacks.com         
EXEL vs. CSLLY Which Stock Is the Better Value Option?
zacks News
six days ago at finance.yahoo.com         
3 Reasons Growth Investors Will Love Exelixis
Yahoo News
over a week ago at investing.com         
Exelixis exec Haley Patrick sells 1.43 million in stock
Investing News at Macroaxis
over a week ago at thelincolnianonline.com         
Phocas Financial Corp. Has 3.76 Million Stock Holdings in Exelixis, Inc.
news
over two weeks ago at zacks.com         
ADMA Biologics Inc Hits Fresh High Is There Still Room to Run?
zacks News
over two weeks ago at investing.com         
Exelixis CSO Aftab Dana sells 3. million in stock
Investing News at Macroaxis
over two weeks ago at finance.yahoo.com         
Heres Why Exelixis is a Strong Value Stock
Yahoo News
over a year ago at gurufocus.com         
Top 5 4th Quarter Trades of BP PLC
Gurufocus Stories at Macroaxis
few days ago at news.google.com         
Collegium Pharmaceutical, Inc. Receives Average Recommendation of Moderate Buy from Brokerages - Mar...
Google News at Macroaxis
over a week ago at thelincolnianonline.com         
Empowered Funds LLC Acquires New Position in Collegium Pharmaceutical, Inc.
news
over a week ago at gurufocus.com         
Rubric Capital Management LP Adjusts Stake in Collegium Pharmaceutical Inc
Gurufocus Stories at Macroaxis
over two weeks ago at finance.yahoo.com         
Is Collegium Pharmaceutical a Great Value Stock Right Now?
Yahoo News
over two weeks ago at gurufocus.com         
Collegium Pharmaceutical Inc Stock Price Down 3.67 percent on Nov 12
Gurufocus Stories at Macroaxis
over two weeks ago at zacks.com         
Is the Options Market Predicting a Spike in Collegium Pharmaceutical Stock?
zacks News
over two weeks ago at finance.yahoo.com         
Collegium Pharmaceutical Inc Q3 2024 Earnings Call Highlights Record Revenue Growth and ...
Yahoo News
over two weeks ago at finance.yahoo.com         
Collegium Pharmaceutical Q3 Earnings Snapshot
Yahoo News
over two weeks ago at finance.yahoo.com         
Heres What Key Metrics Tell Us About Collegium Pharmaceutical Q3 Earnings
Yahoo News
over two weeks ago at gurufocus.com         
What To Expect From Collegium Pharmaceutical Inc Q3 2024 Earnings
Gurufocus Stories at Macroaxis
2 days ago at www.macroaxis.com         
Acquisition by Ferrante Karen Jean of 2513 shares of Cogent Biosciences at 8.02 subject to Rule 16b-...
Macroaxis News
over a week ago at gurufocus.com         
COMMODORE CAPITAL LPs Strategic Acquisition in Cogent Biosciences Inc
Gurufocus Stories at Macroaxis
over two weeks ago at thelincolnianonline.com         
Cogent Biosciences Earns Neutral Rating from Wedbush
news
over two weeks ago at seekingalpha.com         
Cogent Biosciences GAAP EPS of -0.64 misses by 0.08
seekingalpha News
over three weeks ago at finance.yahoo.com         
Cogent Biosciences Announces Bezuclastinib Presentations at the 66th Annual American Society of Hema...
Yahoo News
over a month ago at thelincolnianonline.com         
Cogent Biosciences Stock Rating Reaffirmed by Needham Company LLC
news
over a month ago at finance.yahoo.com         
Analysts Rate Cogent Biosciences, Inc. as Moderate Buy with 15 Target
Yahoo News
over two months ago at thelincolnianonline.com         
Citigroup Increases Cogent Biosciences Price Target to 15.00
news
over two months ago at finance.yahoo.com         
Cogent Biosciences, Inc. This Small-Cap Healthcare Stock Is A Good Buy Right Now
Yahoo News
over three months ago at news.google.com         
Hennion Walsh Asset Management Inc. Invests 1.08 Million in Cogent Biosciences, Inc. - MarketBeat
Google News at Macroaxis
a day ago at gurufocus.com         
Coherus Management to Participate in the 2024 Citi Global Healthcare Conference
Gurufocus Stories at Macroaxis
over a week ago at thelincolnianonline.com         
Coherus BioSciences, Inc. Short Interest Up 5.6 percent in October
news
over two weeks ago at gurufocus.com         
Coherus BioSciences Inc Q3 2024 Earnings Call Highlights Strong Revenue Growth Amid ...
Gurufocus Stories at Macroaxis
over two weeks ago at globenewswire.com         
Coherus BioSciences Reports Third Quarter 2024 Financial Resultsand Provides Business Update
Macroaxis News: globenewswire.com
over three weeks ago at gurufocus.com         
Coherus BioSciences Inc Q3 2024 Everything You Need to Know Ahead of Earnings
Gurufocus Stories at Macroaxis
over three weeks ago at zacks.com         
Acadia Healthcare Beats Q3 Earnings Estimates
zacks News
over a month ago at news.google.com         
Coherus BioSciences, Inc. Receives Average Rating of Moderate Buy from Analysts - MarketBeat
Google News at Macroaxis
over two months ago at simplywall.st         
Revenues Working Against Coherus BioSciences, Inc.s Share Price Following 27 percent Dive
Simply Wall St News at Macroaxis
over two months ago at news.google.com         
HC Wainwright Weighs in on Coherus BioSciences, Inc.s FY2028 Earnings - MarketBeat
Google News at Macroaxis
over two months ago at news.google.com         
Coherus BioSciences, Inc. Short Interest Up 6.0 percent in August - MarketBeat
Google News at Macroaxis
3 days ago at finance.yahoo.com         
AffyImmune Appoints Deyaa Adib, MD as Chief Medical Officer
Yahoo News
six days ago at news.google.com         
Disposition of 9824 shares by Coats Lonnel of Blueprint Medicines at 94.87 subject to Rule 16b-3
Google News at Macroaxis
over a week ago at news.google.com         
Prime Capital Investment Advisors LLC Sells 6,476 Shares of Blueprint Medicines Co. - MarketBeat
Google News at Macroaxis
over a week ago at investing.com         
Blueprint Medicines stock underpriced with 2bn peak sales in sight, per JPMorgan
Investing News at Macroaxis
over two weeks ago at thelincolnianonline.com         
97,861 Shares in Blueprint Medicines Co. Bought by MG Plc
news
over three weeks ago at thelincolnianonline.com         
Blueprint Medicines Co. Shares Bought by Emerald Advisers LLC
news
over three weeks ago at thelincolnianonline.com         
Blueprint Medicines Buy Rating Reaffirmed at Needham Company LLC
news
over three weeks ago at thelincolnianonline.com         
Wedbush Boosts Earnings Estimates for Blueprint Medicines
news
over three weeks ago at thelincolnianonline.com         
Wedbush Research Analysts Lift Earnings Estimates for BPMC
news
over three weeks ago at zacks.com         
Blueprint Medicines Reports Q3 Loss, Tops Revenue Estimates
zacks News
a day ago at finance.yahoo.com         
Why Is BioMarin Pharmaceutical Inc. Among the Worst Performing Healthcare Stocks in 2024?
Yahoo News
six days ago at zacks.com         
Heres Why BioMarin Pharmaceutical is a Strong Value Stock
zacks News
six days ago at insidermonkey.com         
Why Is BioMarin Pharmaceutical Inc. Among the Worst Performing Biotech Stocks in 2024?
insidermonkey News
over a week ago at finance.yahoo.com         
BioMarin Presents Real-World Evidence Further Supporting Safety and Efficacy of VOXZOGO in Children ...
Yahoo News
over a week ago at gurufocus.com         
Insider Sale at Biomarin Pharmaceutical Inc by EVP, Chief Technical Officer Charles Guyer
Gurufocus Stories at Macroaxis
over two weeks ago at zacks.com         
Implied Volatility Surging for BioMarin Pharmaceutical Stock Options
zacks News
over two weeks ago at businesswire.com         
RIBOMIC annonce des rsultats intermdiaires positifs dun essai de phase IIa sur lumedaptanib pegol da...
businesswire News
over three weeks ago at businesswire.com         
RIBOMIC Announces Positive Interim Results from Phase IIa Trial of umedaptanib pegol in Achondroplas...
businesswire News
over three weeks ago at finance.yahoo.com         
Why BioMarin Pharmaceutical is a Top Value Stock for the Long-Term
Yahoo News
over three weeks ago at zacks.com         
Why BioMarin Pharmaceutical is a Top Growth Stock for the Long-Term
zacks News
a day ago at seekingalpha.com         
FDA investigating safety risks of bluebirds Skysona
seekingalpha News
over a week ago at prnewswire.com         
BLUE CROSS BLUE SHIELD OF MASSACHUSETTS ANNOUNCES NEW GRANTS AS PART OF ONGOING WORK TO ADDRESS HEAL...
prnewswire News
over a week ago at investing.com         
JPMorgan skeptical of bluebird bio stock recovery, downgrades to underweight
Investing News at Macroaxis
over a week ago at thelincolnianonline.com         
bluebird bio Downgraded by JPMorgan Chase Co. to Underweight
news
over a week ago at businesswire.com         
bluebird bio Reports Third Quarter 2024 Results and Highlights Operational Progress and 2024 Guidanc...
businesswire News
over two weeks ago at prnewswire.com         
BLUE CROSS BLUE SHIELD OF MASSACHUSETTS CONTINUES TO EXPAND ACCESS TO WOMENS HEALTH SERVICES AND FAM...
prnewswire News
over two weeks ago at prnewswire.com         
BLUE CROSS BLUE SHIELD OF MASSACHUSETTS LAUNCHES REFRESHED HEALTH EQUITY BUSINESS ACCELERATOR WITH M...
prnewswire News
over two weeks ago at finance.yahoo.com         
After Plunging -22.76 percent in 4 Weeks, Heres Why the Trend Might Reverse for Bluebird
Yahoo News
over two weeks ago at businesswire.com         
Acquisition by Vachon Mark of 49850 shares of Bluebird Bio at 0.44 subject to Rule 16b-3
businesswire News
over three weeks ago at businesswire.com         
bluebird bio to Present Additional Long-Term Follow-up Data from Gene Therapy Programs in Sickle Cel...
businesswire News
a minute ago at kalkinemedia.com         
Japan gives priority review status to Alzheimers drug developed by Eisai, Biogen
news
a day ago at simplywall.st         
Is Biogen Inc.s Recent Price Movement Underpinned By Its Weak Fundamentals?
Simply Wall St News at Macroaxis
3 days ago at kalkinemedia.com         
Biogens Stock Outlook Analysts Views on Its Future Performance
news
few days ago at insidermonkey.com         
Goldman Sachs Biogen Inc. Is A Top Growth Investor Stock
insidermonkey News
over a week ago at finance.yahoo.com         
Biogen Inc. Among the Best Genomics Stocks to Buy Right Now
Yahoo News
over a week ago at insidermonkey.com         
Biogen Inc. Among the Best Genomics Stocks to Buy Right Now
insidermonkey News
over a week ago at seekingalpha.com         
Biogen, UCB release phase 3 data on lupus candidate dapirolizumab
seekingalpha News
over a week ago at finance.yahoo.com         
Samsung Bioepis and Biogen Receive European Commission Approval for Aflibercept Biosimilar, OPUVIZ
Yahoo News
over a week ago at seekingalpha.com         
Biogen cut to hold by Needham on lack of catalysts, slow Leqembi sales
seekingalpha News
over a week ago at finance.yahoo.com         
Biogens Outlook Dims As Analyst Projects Flat Revenue Until 2026
Yahoo News
over a year ago at finance.yahoo.com         
Orphan Drug Market Size Share to Surpass 3199.3 Billion by 2028 Vantage Market Research
Yahoo News
over a week ago at news.google.com         
Allakos Reports Q3 2024 Results and Research Progress - TipRanks
Google News at Macroaxis
over two weeks ago at news.google.com         
FMR LLCs Strategic Acquisition of Allakos Inc Shares - GuruFocus.com
Google News at Macroaxis
over a month ago at simplywall.st         
Allakos Insiders Miss 24 percent Gain After Offloading Stock
Simply Wall St News at Macroaxis
over a month ago at thelincolnianonline.com         
JMP Securities Reaffirms Market Outperform Rating for Allakos
news
over two months ago at news.google.com         
Allakos stock plunges to 52-week low of 0.56 amid market challenges - Investing.com
Google News at Macroaxis
over two months ago at www.macroaxis.com         
Disposition of 13665 shares by Radford Harlan Baird of Allakos at 0.65 subject to Rule 16b-3
Macroaxis News
over three months ago at news.google.com         
Vanguard Group Inc. Raises Stock Holdings in Allakos Inc. - Defense World
Google News at Macroaxis
over three months ago at news.google.com         
Allakos stock plunges to 52-week low of 0.67 amid steep annual decline - Investing.com
Google News at Macroaxis
over three months ago at finance.yahoo.com         
Allakos Provides Business Update and Reports Second Quarter 2024 Financial Results
Yahoo News
over three months ago at finance.yahoo.com         
Can Allakos Afford To Invest In Growth?
Yahoo News
over a year ago at news.google.com         
Current and Future Analysis of Rho Kinases Inhibitor Market With New Business Strategies and Forecas...
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Alphacentric Lifesci that are available to investors today. That information is available publicly through Alphacentric media outlets and privately through word of mouth or via Alphacentric internal channels. However, regardless of the origin, that massive amount of Alphacentric data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Alphacentric Lifesci news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Alphacentric Lifesci relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Alphacentric Lifesci's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Alphacentric Lifesci alpha.

Other Information on Investing in Alphacentric Mutual Fund

Alphacentric Lifesci financial ratios help investors to determine whether Alphacentric Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Alphacentric with respect to the benefits of owning Alphacentric Lifesci security.
Global Correlations
Find global opportunities by holding instruments from different markets
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance